全文获取类型
收费全文 | 6470篇 |
免费 | 398篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 176篇 |
儿科学 | 378篇 |
妇产科学 | 66篇 |
基础医学 | 670篇 |
口腔科学 | 78篇 |
临床医学 | 499篇 |
内科学 | 1454篇 |
皮肤病学 | 144篇 |
神经病学 | 476篇 |
特种医学 | 223篇 |
外科学 | 1084篇 |
综合类 | 179篇 |
一般理论 | 2篇 |
预防医学 | 472篇 |
眼科学 | 108篇 |
药学 | 388篇 |
中国医学 | 5篇 |
肿瘤学 | 483篇 |
出版年
2023年 | 35篇 |
2022年 | 72篇 |
2021年 | 202篇 |
2020年 | 118篇 |
2019年 | 170篇 |
2018年 | 229篇 |
2017年 | 174篇 |
2016年 | 176篇 |
2015年 | 211篇 |
2014年 | 308篇 |
2013年 | 342篇 |
2012年 | 487篇 |
2011年 | 488篇 |
2010年 | 256篇 |
2009年 | 230篇 |
2008年 | 409篇 |
2007年 | 386篇 |
2006年 | 359篇 |
2005年 | 290篇 |
2004年 | 284篇 |
2003年 | 281篇 |
2002年 | 218篇 |
2001年 | 86篇 |
2000年 | 73篇 |
1999年 | 79篇 |
1998年 | 72篇 |
1997年 | 75篇 |
1996年 | 68篇 |
1995年 | 39篇 |
1994年 | 36篇 |
1993年 | 27篇 |
1992年 | 38篇 |
1991年 | 36篇 |
1990年 | 36篇 |
1989年 | 34篇 |
1988年 | 46篇 |
1987年 | 28篇 |
1986年 | 35篇 |
1985年 | 37篇 |
1984年 | 20篇 |
1983年 | 26篇 |
1982年 | 26篇 |
1981年 | 28篇 |
1980年 | 19篇 |
1979年 | 18篇 |
1978年 | 17篇 |
1977年 | 18篇 |
1976年 | 15篇 |
1973年 | 16篇 |
1972年 | 18篇 |
排序方式: 共有6885条查询结果,搜索用时 15 毫秒
31.
Meltem Yüksel Elma Baron Melissa Camouse Brenda W Cooper Hillard M Lazarus Stanton L Gerson Mary J Laughlin Kevin D Cooper Anita Gilliam Pingfu Fu Seth Stevens Omer N Ko? 《Biology of blood and marrow transplantation》2006,12(6):665-671
Whole-body UV-B phototherapy has been used for the treatment of graft-versus-host disease (GVHD) of the skin and has systemic immunosuppressive and tolerogenic effects. We hypothesized that whole-body UV-B therapy would improve donor engraftment and decrease the incidence and severity of GVHD that is associated with decreased intensity allogeneic hematopoietic stem cell transplantation. This study tested the feasibility of using UV-B phototherapy that was initiated before grafting and continued until engraftment to determine its effect on transplantation outcome. Eight patients (median age, 55.5 years; range, 32-65 years) with hematologic malignancies were included. Allogeneic peripheral blood stem cells were obtained from matched related (n=5) or matched unrelated (n=3) donors. Conditioning regimen was fludarabine 30 mg/m2 intravenously for 5 days, cyclophosphamide 1 g/m2/d intravenously for 2 days, and equine antithymocyte globulin 30 mg/kg/d for 2 days. GVHD prophylaxis included cyclosporine, methylprednisolone, and escalating doses of narrowband UV-B (311 nm) according to skin tolerance, 3 days a week, from 10 days before to 28 days after transplantation. The conditioning regimen and the UV-B therapy were well tolerated. Two patients received all 14 prescribed UV-B treatments (cumulative doses of 2000 and 3260 mJ/cm2, respectively) and 6 patients received 8 to 13 treatments with a cumulative dose range of 528-3465 mJ/cm2. There was a rapid decrease in epidermal CD1a+ cells by day of transplantation. Myeloid engraftment was rapid. One patient had secondary engraftment failure at 3 months and another had mixed chimerism at day 100. Seven of 8 patients developed severe acute GVHD (grade III, n=5; grade IV, n=2). Six had skin involvement, 5 had gastrointestinal involvement, and 1 had liver involvement. Four patients died (2 from sepsis, 1 from acute GVHD, and 1 from chronic GVHD). Four patients are alive (130-287 days), 3 with extensive chronic GVHD. We conclude that extended peritransplant UV-B therapy at the standard minimally erythemogenic dose is detrimental to the outcome of allogeneic stem cell transplantation. It is unclear how UV-B at this immunsuppressive dose might have altered skin and systemic cytokine and immune cell compositions in the host and increased GVHD- and treatment-related mortalities. Different UV-B dose and schedules should be further explored. However, although other phototherapeutic modalities may be effective against GVHD, extended UV-B therapy should not be used during early phases of decreased conditioning allogeneic transplantation. 相似文献
32.
33.
In our sample of 15 hospitalized patients with severe psychotic depression, six responded to therapy with tricyclic antidepressants combined with neuroleptics. Of the nine nonresponders, eight showed an excellent clinical response to electroconvulsive therapy (ECT). The clinical outcome after 6 months of treatment was similar in both groups. We recommend that protracted, complicated trials of pharmacotherapy be reevaluated in psychotic depression. A prospective comparative study of ECT and pharmacotherapy is needed to define the optimal treatment for psychotic depression. 相似文献
34.
Cobb Cory L. Salas-Wright Christopher P. John Rachel Schwartz Seth J. Vaughn Michael Martínez Charles R. Awad Germine Pinedo Miguel Cano Miguel Ángel 《Prevention science》2021,22(3):397-407
Prevention Science - We examined national trends and mental health correlates of discrimination among Latinos in the USA. We used data from two nationally representative surveys based on the... 相似文献
35.
36.
37.
38.
39.
Roger Suau Marta Vidal Ruth Aguilar Gemma Ruiz-Olalla Miquel Vázquez-Santiago Chenjerai Jairoce Augusto J. Nhabomba Ben Gyan David Dosoo Kwaku Poku Asante Seth Owusu-Agyei Joseph J. Campo Luis Izquierdo David Cavanagh Ross L. Coppel Virander Chauhan Evelina Angov Sheetij Dutta Carlota Dobaño 《Vaccine》2021,39(4):687-698
BackgroundThe evaluation of immune responses to RTS,S/AS01 has traditionally focused on immunoglobulin (Ig) G antibodies that are only moderately associated with protection. The role of other antibody isotypes that could also contribute to vaccine efficacy remains unclear. Here we investigated whether RTS,S/AS01E elicits antigen-specific serum IgA antibodies to the vaccine and other malaria antigens, and we explored their association with protection.MethodsNinety-five children (age 5–17 months old at first vaccination) from the RTS,S/AS01E phase 3 clinical trial who received 3 doses of RTS,S/AS01E or a comparator vaccine were selected for IgA quantification 1 month post primary immunization. Two sites with different malaria transmission intensities (MTI) and clinical malaria cases and controls, were included. Measurements of IgA against different constructs of the circumsporozoite protein (CSP) vaccine antigen and 16 vaccine-unrelated Plasmodium falciparum antigens were performed using a quantitative suspension array assay.ResultsRTS,S vaccination induced a 1.2 to 2-fold increase in levels of serum/plasma IgA antibodies to all CSP constructs, which was not observed upon immunization with a comparator vaccine. The IgA response against 13 out of 16 vaccine-unrelated P. falciparum antigens also increased after vaccination, and levels were higher in recipients of RTS,S than in comparators. IgA levels to malaria antigens before vaccination were more elevated in the high MTI than the low MTI site. No statistically significant association of IgA with protection was found in exploratory analyses.ConclusionsRTS,S/AS01E induces IgA responses in peripheral blood against CSP vaccine antigens and other P. falciparum vaccine-unrelated antigens, similar to what we previously showed for IgG responses. Collectively, data warrant further investigation of the potential contribution of vaccine-induced IgA responses to efficacy and any possible interplay, either synergistic or antagonistic, with protective IgG, as identifying mediators of protection by RTS,S/AS01E immunization is necessary for the design of improved second-generation vaccines.Clinical trial registration: ClinicalTrials.gov: NCT008666191. 相似文献